|
17.07.2013 20:01:00
|
Moody's: "Value Over Volume" Reimbursement Models Challenge Device Makers and Hospitals; Benefit Insurers
New York, July 17, 2013 -- Various sectors of the US healthcare industry will see mixed effects as they transition to delivery and reimbursement models that emphasize quality care over quantity of care, as encouraged by the Affordable Care Act, Moody's Investors Service says in a new report. Medical device makers will be the most vulnerable; both for-profit and not-for-profit hospitals will face risks during the transition; insurers stand to gain the most.
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.